DAVID R BETHUNE Insider Trading $VERU VERU INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID R BETHUNE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID R BETHUNE. DAVID R BETHUNE is CEO/Chairman in ATRIX LABORATORIES INC ($ATRX) and Chief Executive Officer in ATRIX LABORATORIES INC ($ATRX) and Director in FEMALE HEALTH CO ($FHCO).
DAVID R BETHUNE in VERU INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID R BETHUNE: Director
Holdings: 575,982 shares
Current Value: $604,781
Latest Transaction: Nov 01 2018
$VERU Market Capitalization: $32.90M
$VERU Previous Close: $1.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DAVID R BETHUNE in VERU INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 01 2018 | VERU | VERU INC. | BETHUNE DAVID R | Director | Option Exercise | M | 0.00 | 140,000 | 0 | 0 | |
| Nov 01 2018 | VERU | VERU INC. | BETHUNE DAVID R | Director | Buy | M | 0.00 | 140,000 | 0 | 575,982 | 436 K to 576 K (+32.11 %) |
| May 04 2018 | VERU | VERU INC. | BETHUNE DAVID R | Director | Option Exercise | A | 1.89 | 50,000 | 94,500 | 50,000 | |
| Aug 04 2017 | FHCO | VERU INC. | BETHUNE DAVID R | Director | Option Exercise | A | 1.20 | 50,000 | 60,000 | 50,000 | |
| May 17 2017 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Buy | P | 1.03 | 10,000 | 10,305 | 435,982 | 426 K to 436 K (+2.35 %) |
| May 15 2017 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Buy | P | 1.03 | 10,000 | 10,299 | 425,982 | 416 K to 426 K (+2.40 %) |
| May 15 2017 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Buy | P | 1.03 | 10,000 | 10,278 | 415,982 | 406 K to 416 K (+2.46 %) |
| Dec 15 2016 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Buy | P | 1.06 | 200 | 212 | 405,982 | 405.8 K to 406 K (+0.05 %) |
| Nov 02 2016 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Option Exercise | A | 0.95 | 140,000 | 133,000 | 420,000 | |
| Nov 02 2016 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Option Exercise | A | 0.00 | 140,000 | 0 | 280,000 | |
| Nov 02 2016 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Option Exercise | A | 0.95 | 140,000 | 133,000 | 140,000 | |
| Nov 02 2016 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Option Exercise | M | 0.00 | 16,667 | 0 | 0 | |
| Nov 02 2016 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Buy | M | 0.00 | 16,667 | 0 | 405,782 | 389.1 K to 405.8 K (+4.28 %) |
| Nov 02 2016 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Grant | A | 0.00 | 140,000 | 0 | 389,115 | 249.1 K to 389.1 K (+56.20 %) |
| Sep 09 2016 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Option Exercise | M | 0.00 | 8,333 | 0 | 0 | |
| Sep 09 2016 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Sell | D | 1.32 | 8,333 | 11,000 | 249,115 | 257.4 K to 249.1 K (-3.24 %) |
| Sep 09 2016 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Buy | M | 0.00 | 8,333 | 0 | 257,448 | 249.1 K to 257.4 K (+3.35 %) |
| May 23 2016 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Buy | P | 1.26 | 100 | 126 | 249,115 | 249 K to 249.1 K (+0.04 %) |
| Aug 28 2015 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Aug 28 2015 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Grant | A | 0.00 | 50,000 | 0 | 249,015 | 199 K to 249 K (+25.12 %) |
Page: 1